The increasing incidence of anal cancer: Can it be explained by trends in risk groups?

Netherlands Journal of Medicine

Volumn 71, Issue 8, 2013, Pages 401-411

  Van der Zee, R P ^a   Richel, O ^a   de Vries, H J C ^a   Prins, J M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Anal cancer; HIV; Incidence; Risk groups

Indexed keywords

ANTIRETROVIRUS AGENT; IMMUNOSUPPRESSIVE AGENT;

ANAL INTERCOURSE; ANUS CANCER; CANCER INCIDENCE; CANCER RISK; DNA VIRUS INFECTION; GRAFT RECIPIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY GRAFT; MEN WHO HAVE SEX WITH MEN; META ANALYSIS (TOPIC); NETHERLANDS; REVIEW; RISK FACTOR; SEXUAL PRACTICE; SMOKING; SYSTEMATIC REVIEW (TOPIC); UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ANUS NEOPLASMS; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HIV SEROPOSITIVITY; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; ORGAN TRANSPLANTATION; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SEXUAL BEHAVIOR; SMOKING; UTERINE CERVICAL NEOPLASMS;

EID: 84885809937     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Uronis HE, Bendell JC. Anal cancer: an overview. Oncologist. 2007;12:524-534.
2. Clark MA, Hartley A, Geh JI. Cancer of the anal canal. Lancet Oncol. 2004;5:149-157.
3. Van Lieshout A, Pronk A. Increasing incidence of anal cancer in the Netherlands. Ned Tijdschr Geneeskd. 2010;154:A1163.
4. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med. 2000;342:792-800.
5. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology and end results experience 1973-2000. Cancer. 2004;101:281-288.
6. Joseph DA, Miller JW, Wu X, et al. Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer. 2008;113(10 Suppl):2892-900.
7. Robinson D, Coupland V, Møller H. An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England. Br J Cancer. 2009;100:527-531.
8. Brewster DH, Bhatti LA. Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975-2002. Br J Cancer. 2006;95:87-90.
9. Nielsen A, Munk C, Kjaer SK. Trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark, 1978-2008. Int J Cancer. 2012;130:1168-1173.
10. Jin F, Stein AN, Conway EL, Regan DG, et al. Trends in anal cancer in Australia, 1982-2005. Vaccine. 2011;29:2322-2327.
11. ICD-10. International Classification of Diseases for Oncology. 10th edition. Geneva: WHO; 2010 (cited 2012 June 30); Available from http://www.who.int/classifcations/icd/en/
12. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). National Cancer Institute. Bethesda, MD, based on November 2011 SEER data submission; 2012 April (cited 2012 June 30); Available from: http://seer.cancer.gov/csr/1975_2009_pops09/
13. Fast Stats: An interactive tool for access to SEER cancer statistics. Surveillance Research Program (homepage on the Internet). National Cancer Institute; (cited 2012 June 30); Available from: http://seer.cancer.gov/faststats/index.php
14. Dutch Cancer Registry (NKR) database (homepage on the Internet). Integral kankercentrum Nederland; (cited 2012 June 30); Available from: http://cijfersoverkanker.nl/
15. Louchini R, Goggin P, Steben M. The evolution of HPV-related anogenital cancers reported in Quebec Incidence rates and survival probabilities. Chronic Dis Can. 2008;28:99-106.
16. Daling JR, Sherman KJ, Hislop TG, et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol. 1992;135:180-189.
17. Daling JR, Madeleine MM, Johnson LG, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer. 2004;101:270-280.
18. Frisch M, Glimelius B, Wohlfahrt J, Adami HO, Melbye M. Tobacco smoking as a risk factor in anal carcinoma: an antiestrogenic mechanism? J Natl Cancer Inst. 1999;91:708-715.
19. Holly EA, Whittemore AS, Aston DA, Ahn DK, Nickoloff BJ, Kristiansen JJ. Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst. 1989;81:1726-1731.
20. Rabkin CS, Biggar RJ, Melbye M, Curtis RE. Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors. Am J Epidemiol. 1992;136:54-58.
21. Frisch M, Olsen JH, Melbye M. Malignancies that occur before and after anal cancer: clues to their etiology. Am J Epidemiol. 1994;140:12-19.
22. Palefsky JM. Human papillomavirus infection in HIV-infected persons. Top HIV Med. 2007;15:130-133.
23. Welton ML, Sharkey FE, Kahlenberg MS. The etiology and epidemiology of anal cancer. Surg Oncol Clin N Am. 2004;13:263-275.
24. Chin-Hong PV, Palefsky JM. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis. 2002;35:1127-1134.
25. Frisch M, Fenger C, van den Brule AJ, et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res. 1999;59:753-757.
26. Roark R. The need for anal dysplasia screening and treatment programs for HIV-infected men who have sex with men: a review of the literature. J Assoc Nurses AIDS Care. 2011;22:433-443.
27. Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer. 2009;124:2375-2383.
28. Kreuter A, Potthoff A, Brockmeyer NH, et al. Anal carcinoma in human immunodeficiency virus- positive men: Results of a prospective study from Germany. Br J Dermatol. 2010;162:1269-1277.
29. Daling JR, Weiss NS, Hislop TG, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med. 1987;317:973-977.
30. Palefsky JM. Human Papillomavirus-Related Disease in Men: Not Just a Women's Issue. J Adolesc Health. 2010;46(4 Suppl):S12-S19.
31. Frisch M, Glimelius B, van den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med. 1997;337:1350-1358.
32. Palefsky JM. Human papillomavirus infection and anogenital neoplasia in human immunodefciency virus-positive men and women. J Natl Cancer Inst Monogr. 1998;23:15-20.
33. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis. 1998;177:361-367.
34. Chin-Hong PV, Vittinghoff E, Cranston RD, et al. Age-related prevalence of anal cancer precursors in homosexual men: The EXPLORE study. J Natl Cancer Inst. 2005;97:896-905.
35. Machalek DA, Poynten M, Jin F, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol. 2012;13:487-500.
36. Chin-Hong PV, Husnik M, Cranston RD, et al. Anal human papillomavirus infection is associated with HIV acquisition in men who have sex with men. AIDS. 2009;23:1135-1142.
37. Critchlow CW, Surawicz CM, Holmes KK, et al. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: Influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS. 1995;9:1255-1262.
38. Palefsky JM, Holly EA, Hogeboom CJ, et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defc Syndr Hum Retrovirol. 1998;17:314-319.
39. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000;92:1500-1510.
40. Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh TM. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS. 1998;12:495-503.
41. Bedimo RJ, McGinnis KA, Dunlap M, Rodriguez-Barradas MC, Justice AC. Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression. J Acquir Immune Defc Syndr. 2009;52:203-208.
42. Guiguet M, Boué F, Cadranel J, et al. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol. 2009;10:1152-1159.
43. de Pokomandy A, Rouleau D, Ghattas G, et al. HAART and Progression to High-Grade Anal Intraepithelial Neoplasia in Men Who Have Sex with Men and Are Infected with HIV. Clin Infect Dis. 2011;52:1174-1181.
44. D'Souza G, Wiley DJ, Li X, et al. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defc Syndr. 2008;48:491-499.
45. Palefsky J. Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS. 2009;4:52-56.
46. Grulich AE, Li Y, McDonald A, Correll PKL, Law MG, Kaldor JM. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS. 2002;16:1155-1161.
47. Grulich AE, Tvan Leeuwen M, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosupressed transplant recipients: a meta-analysis. Lancet. 2007;370:59-67.
48. Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defc Syndr. 2009;52:611-622.
49. Silverberg MJ, Lau B, Justice AC, et al. Risk of Anal Cancer in HIV-Infected and HIV-Uninfected Individuals in North America. Clin Infect Dis. 2012;54:1026-1034.
50. Piketty C, Selinger-Leneman H, Grabar S, et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS. 2008;22:1203-1211.
51. Palefsky JM, Gillison ML, Strickler HD. Chapter 16: HPV vaccines in immunocompromised women and men. Vaccine. 2006;24(Suppl 3):S3/140-6.
52. Patel HS, Silver AR, Northover JM. Anal cancer in renal transplant patients. Int J Colorectal Dis. 2007;22:1-5.
53. Parnaby CN, Barrow EJ, Edirimanne SB, Parrott NR, Frizelle FA, Watson AJ. Colorectal complications of end-stage renal failure and renal transplantation: a review. Colorectal Dis. 2012;14:403-415.
54. Arends MJ, Benton EC, McLaren KM, Stark LA, Hunter JA, Bird CC. Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy. Br J Cancer. 1997;75:722-728.
55. Sillman F, Stanek A, Sedlis A, et al. The relationship between human papillomavirus and lower genital intraepithelial neoplasia in immunosuppressed women. Am J Obstet Gynecol. 1984;150:300-308.
56. Sillman FH, Sedlis A. Anogenital papillomavirus infection and neoplasia in immunodefcient women: an update. Dermatol Clin. 1991;9:353-69.
57. Sillman FH, Fruchter RG, Chen YS, Camilien L, Sedlis A, McTigue E. Vaginal intraepithelial neoplasia: risk factors for persistence, recurrence, and invasion and its management. Am J Obstet Gynecol. 1997;176(Pt 1):93-99.
58. Roka S, Rasoul-Rockenschaub S, Roka J, Kirnbauer R, Mühlbacher F, Salat A. Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression. Transpl Int. 2004:366-369.
59. Sunesen KG, Nørgaard M, Thorlacius-Ussing O, Laurberg S. Immunosuppressive disorders and risk of anal squamous cell carcinoma: a nationwide cohort study in Denmark, 1978-2005. Int J Cancer. 2010;127:675-684.
60. Engels EA, Pfeiffer RM, Fraumeni JF Jr, et al. Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients. JAMA. 2011;306:1891-1901.
61. Peters RK, Mack TM, Bernstein L. Parallels in the epidemiology of selected anogenital carcinomas. J Natl Cancer Inst. 1984;72:609-615.
62. Edgren G, Sparén P. Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study. Lancet Oncol. 2007;8:311-316.
63. Saleem AM, Paulus JK, Shapter AP, Baxter NN, Roberts PL, Ricciardi R. Risk of Anal Cancer in a Cohort With Human Papillomavirus-Related Obstet Gynecol. 2011;117:643-649.
64. Bower M, Powles T, Newsom-Davis T, et al. HIV-Associated Anal Cancer: Has Highly Active Antiretroviral Therapy Reduced the Incidence or Improved the Outcome? J Acquir Immune Defc Syndr. 2004;37:1563-1565.
65. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med. 2008;148:728-736.
66. Gras L, Van Sighem A, Smit C, Zaheri S, Schuitemaker H, De Wolf F. Monitoring report 2007: Human Immunodeficiency Virus (HIV) Infection in The Netherlands. Amsterdam: Stichting HIV Monitoring (Dutch HIV monitoring foundation); 2007 (cited 2012 June 30); Available from: www.hiv-monitoring.nl
67. Van Sighem A, Smit C, Gras L, et al. Monitoring report 2011: Human Immunodeficiency Virus (HIV) Infection in The Netherlands. Amsterdam: Stichting HIV Monitoring (Dutch HIV monitoring foundation); 2011 (cited 2012 June 30); Available from: www.hiv-monitoring.nl
68. Hemke AC, Dekker FW, Bos WJ, Krediet RT, Heemskerk MB, Hoitsma AJ. Causes of decreased use of peritoneal dialysis as a kidney replacement therapy in the Netherlands. Ned Tijdschr Geneeskd. 2012;156:A3871.
69. Draper H, Frenken F. Aantal rokers daalt nog steeds, de verkoop van sigaretten echter niet meer. Webmagazine Centraal Bureau voor de Statistiek (CBS) (Dutch Statistics Centre), (serial on the Internet). 2008 June 23; (cited 2012 June 30); Available from: http://www.cbs.nl/nl-NL/menu/themas/gezondheid-welzijn/publicaties/artikelen/archief/2008/2008-2458-wm.htm
70. Frisch M, Melbye M, Møller H. Trends in incidence of anal cancer in Denmark. BMJ. 1993;306:419-422.